These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054 [TBL] [Abstract][Full Text] [Related]
24. Prevention of postoperative thromboembolisms in general surgery by the combination of heparin and dihydroergotamine. Sándor T; László E; Magyary F; Turcsányi G; Hetényi L; Izinger E Acta Chir Hung; 1986; 27(2):107-14. PubMed ID: 3529772 [TBL] [Abstract][Full Text] [Related]
25. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136 [TBL] [Abstract][Full Text] [Related]
26. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623 [TBL] [Abstract][Full Text] [Related]
27. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025 [TBL] [Abstract][Full Text] [Related]
28. Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty. Hampson WG; Harris FC; Lucas HK; Roberts PH; McCall IW; Jackson PC; Powell NL; Staddon GE Lancet; 1974 Oct; 2(7884):795-7. PubMed ID: 4138905 [No Abstract] [Full Text] [Related]
29. [Heparin in low dosage as prophylaxis of postoperative pulmonary embolism and deep venous thrombosis]. Kiil J; Kiil J; Axelsen F Ugeskr Laeger; 1978 May; 140(21):1224-30. PubMed ID: 351904 [No Abstract] [Full Text] [Related]
30. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement]. Weber U; Koppenhagen K; Mälzer H; Matthes M Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434 [TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Hull RD; Gent M N Engl J Med; 1986 Oct; 315(15):925-9. PubMed ID: 3531851 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125 [TBL] [Abstract][Full Text] [Related]
33. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin. Hohl MK; Lüscher KP; Tichý J; Stiner M; Fridrich R; Gruber UF; Käser O Obstet Gynecol; 1980 Apr; 55(4):497-500. PubMed ID: 6154272 [TBL] [Abstract][Full Text] [Related]
34. Hypotensive anesthesia, thromboprophylaxis and postoperative thromboembolism in total hip arthroplasty. Fredin H; Gustafson C; Rosberg B Acta Anaesthesiol Scand; 1984 Oct; 28(5):503-7. PubMed ID: 6208742 [TBL] [Abstract][Full Text] [Related]
35. Prevention of Fatal Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Kakkar VV; Corrigan TP; Fossard DP; Sutherland I; Thirwell J Lancet; 1977 Mar; 1(8011):567-9. PubMed ID: 65660 [TBL] [Abstract][Full Text] [Related]
36. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran. Verstraete M Surg Gynecol Obstet; 1976 Dec; 143(6):981-5. PubMed ID: 996722 [TBL] [Abstract][Full Text] [Related]
37. [Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)]. Adolf J; Buttermann G; Weidenbach A; Gmeineder F Geburtshilfe Frauenheilkd; 1978 Feb; 38(2):98-104. PubMed ID: 631536 [TBL] [Abstract][Full Text] [Related]
38. Prophylaxis against postoperative pulmonary embolism and deep-vein thrombosis by low-dose heparin. Kiil J; Kiil J; Axelsen F; Andersen D Lancet; 1978 May; 1(8074):1115-6. PubMed ID: 77413 [TBL] [Abstract][Full Text] [Related]
39. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742 [TBL] [Abstract][Full Text] [Related]
40. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee. JAMA; 1984 Jun; 251(22):2960-6. PubMed ID: 6371278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]